Zhuhai Rundu Pharmaceutical Co Ltd Class A Cash Flow-to-Debt Ratio
Zhuhai Rundu Pharmaceutical Co Ltd Class A cash flow-to-debt ratio. Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥37.78 Million could theoretically repay 0% of its total liabilities (CN¥1.03 Billion) in one year. Check Zhuhai Rundu Pharmaceutical Co Ltd Class cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)
Cash flow-to-debt ratio of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025. Historical debt coverage capacity for Zhuhai Rundu Pharmaceutical Co Ltd Class A across 15 annual periods. Check 002923 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Cash Flow-to-Debt Ratio by Year (2011–2025)
Zhuhai Rundu Pharmaceutical Co Ltd Class A cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Zhuhai Rundu Pharmaceutical Co Ltd Class A. For the full cash flow conversion analysis, see 002923 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥104.41 Million | CN¥990.19 Million | ▼ -48.0% |
| 2024 | 0.20x | CN¥211.19 Million | CN¥1.04 Billion | ▲ +23.1% |
| 2023 | 0.16x | CN¥172.68 Million | CN¥1.05 Billion | ▲ +33.0% |
| 2022 | 0.12x | CN¥135.01 Million | CN¥1.09 Billion | ▼ -52.1% |
| 2021 | 0.26x | CN¥205.91 Million | CN¥797.28 Million | ▼ -50.9% |
| 2020 | 0.53x | CN¥250.35 Million | CN¥475.54 Million | ▲ +34.4% |
| 2019 | 0.39x | CN¥151.30 Million | CN¥386.39 Million | ▼ -34.2% |
| 2018 | 0.60x | CN¥159.04 Million | CN¥267.13 Million | ▲ +123.1% |
| 2017 | 0.27x | CN¥57.95 Million | CN¥217.16 Million | ▼ -38.0% |
| 2016 | 0.43x | CN¥94.07 Million | CN¥218.42 Million | ▲ +62.3% |
| 2015 | 0.27x | CN¥50.14 Million | CN¥189.00 Million | ▼ -53.3% |
| 2014 | 0.57x | CN¥58.01 Million | CN¥102.10 Million | ▲ +94.2% |
| 2013 | 0.29x | CN¥31.67 Million | CN¥108.25 Million | ▼ -60.5% |
| 2012 | 0.74x | CN¥70.01 Million | CN¥94.63 Million | ▲ +60.9% |
| 2011 | 0.46x | CN¥33.71 Million | CN¥73.29 Million | — |